Sanchai Chasombat

Summary

Publications

  1. ncbi The National Access to Antiretroviral Program for PHA (NAPHA) in Thailand
    Sanchai Chasombat
    Bureau of AIDS, TB and STIs, Department of Disease Control, Ministry of Public Health, Thailand
    Southeast Asian J Trop Med Public Health 37:704-15. 2006
  2. ncbi National expansion of antiretroviral treatment in Thailand, 2000-2007: program scale-up and patient outcomes
    Sanchai Chasombat
    Bureau of AIDS, Tuberculosis, and Sexually Transmitted Infections, Department of Disease Control, Ministry of Public Health, Nonthaburi, Thailand
    J Acquir Immune Defic Syndr 50:506-12. 2009
  3. ncbi Public health in Thailand: emerging focus on non-communicable diseases
    Nicholas D Kaufman
    Praboromarajchanok Institute, Ministry of Public Health, Thailand
    Int J Health Plann Manage 26:e197-212. 2011
  4. ncbi High rate multiple drug resistances in HIV-infected patients failing nonnucleoside reverse transcriptase inhibitor regimens in Thailand, where subtype A/E is predominant
    Ploenchan Chetchotisakd
    Srinagarind Hospital, Khon Kaen University, Khon Kaen 40002, Thailand
    J Int Assoc Physicians AIDS Care (Chic) 5:152-6. 2006
  5. ncbi Genotypic resistance mutations in treatment-naïve and treatment-experienced patients under widespread use of antiretroviral drugs in Thailand: implications for further epidemiologic surveillance
    Chonlaphat Sukasem
    Department of Pathobiology, Faculty of Science, Mahidol University, Bangkok, Thailand
    Jpn J Infect Dis 60:284-9. 2007

Collaborators

  • Sombat Thanprasertsuk
  • Michelle S McConnell
  • Nicholas D Kaufman
  • R Sutthent
  • Chonlaphat Sukasem
  • Ploenchan Chetchotisakd
  • Suda Riengrojpitak
  • Vina Churdboonchart
  • Kanjana Sirisidthi
  • Montip Tiensuwan
  • Wantanich Piroj
  • Chotip Watitpun
  • Wasun Chantratita
  • Manassinee Horsakulthai
  • Khuanchai Supparatpinyo
  • Siriluck Anunnatsiri
  • Boonchai Kowadisaiburana
  • Thanomsak Anekthananon
  • Sasisopin Kiertiburanakul
  • Kiat Ruxrungtham
  • Chureeratana Bowonwatanuwong

Detail Information

Publications5

  1. ncbi The National Access to Antiretroviral Program for PHA (NAPHA) in Thailand
    Sanchai Chasombat
    Bureau of AIDS, TB and STIs, Department of Disease Control, Ministry of Public Health, Thailand
    Southeast Asian J Trop Med Public Health 37:704-15. 2006
    ..Lessons learned from the program initiation and scaling up show local leadership, comprehensive training, adherence, and coordination are essential to program effectiveness and sustainability...
  2. ncbi National expansion of antiretroviral treatment in Thailand, 2000-2007: program scale-up and patient outcomes
    Sanchai Chasombat
    Bureau of AIDS, Tuberculosis, and Sexually Transmitted Infections, Department of Disease Control, Ministry of Public Health, Nonthaburi, Thailand
    J Acquir Immune Defic Syndr 50:506-12. 2009
    ..We describe program scale-up and patient outcomes from 2000 to 2007...
  3. ncbi Public health in Thailand: emerging focus on non-communicable diseases
    Nicholas D Kaufman
    Praboromarajchanok Institute, Ministry of Public Health, Thailand
    Int J Health Plann Manage 26:e197-212. 2011
    ....
  4. ncbi High rate multiple drug resistances in HIV-infected patients failing nonnucleoside reverse transcriptase inhibitor regimens in Thailand, where subtype A/E is predominant
    Ploenchan Chetchotisakd
    Srinagarind Hospital, Khon Kaen University, Khon Kaen 40002, Thailand
    J Int Assoc Physicians AIDS Care (Chic) 5:152-6. 2006
    ..Eighty-nine percent of patients had 1 or more NNRTI mutation resistances. Almost all patients had resistance to at least 1 nucleoside reverse transcriptase inhibitor (NRTI), and 42% had multiple-NRTI resistance...
  5. ncbi Genotypic resistance mutations in treatment-naïve and treatment-experienced patients under widespread use of antiretroviral drugs in Thailand: implications for further epidemiologic surveillance
    Chonlaphat Sukasem
    Department of Pathobiology, Faculty of Science, Mahidol University, Bangkok, Thailand
    Jpn J Infect Dis 60:284-9. 2007
    ..We also recommend routine genotypic testing in treatment-naive patients before starting antiretroviral therapy to prevent subtherapeutic response and viral failure...